REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Sayre Therapeutics Private Limited (India)

Main Activities: Health Care and Social Assistance
Full name: Sayre Therapeutics Private Limited Profile Updated: January 13, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Sayre Therapeutics Private Limited is an unlisted company, incorporated on 07/04/2015. It has its registered office in the State of Karnataka, India. Company's corporate identification number (CIN) is U85110KA2015PTC079687 and registration number is 079687.

Legal Address
Flat No.1104, Sobha Cinnamon Apartment, Haralur Road,
Bangalore; Karnataka; Postal Code: 560102

Contact Details: Purchase the Sayre Therapeutics Private Limited report to view the information.

Website: http://sayretherapeutics.com

Basic Information
Total Employees:
Purchase the Sayre Therapeutics Private Limited report to view the information.
Registered Capital:
Purchase the Sayre Therapeutics Private Limited report to view the information.
Financial Auditors:
Purchase the Sayre Therapeutics Private Limited report to view the information.
Incorporation Date:
April 07, 2015
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Professional Director
Ownership Details
Purchase this report to view the information.
86.44%
Subsidiaries
Rayes Inc
100%
Company Performance
Financial values in the chart are available after Sayre Therapeutics Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
18.25%▲
Total operating revenue
23.36%▲
Operating profit (EBIT)
258.09%▲
EBITDA
256.71%▲
Net Profit (Loss) for the Period
N/A
Total Assets
0.63%▲
Total Equity
5.68%▲
Operating Profit Margin (ROS)
6.9%▲
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt/Equity
-8.7%▼
Quick Ratio
-0.05%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo